Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM.
Ines SellamiAnne MayeurAlexandra BenoitFayçal ZeghariMaeliss PeignéJad RoufaelMichaël GrynbergCharlotte SonigoPublished in: Journal of assisted reproduction and genetics (2023)
The indication of NAC for BC should not be considered as an impediment to urgent COS for oocyte vitrification for FP.